{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:51:40Z","timestamp":1747162300231,"version":"3.40.5"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ijid.2022.07.046","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T03:23:26Z","timestamp":1658460206000},"page":"976-978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Chronic active Epstein-Barr exacerbated by COVID-19 co-infection"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3991-9949","authenticated-orcid":false,"given":"David B","family":"Villafuerte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2102-2503","authenticated-orcid":false,"given":"Olga","family":"Lavrynenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8797-3619","authenticated-orcid":false,"given":"Rayan","family":"Qazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco F","family":"Passeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando L","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2022.07.046_bib0001","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1182\/blood-2018-03-785931","article-title":"How I treat T-cell chronic active Epstein-Barr virus disease","volume":"131","author":"Bollard","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ijid.2022.07.046_bib0002","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein-Barr virus infection","volume":"343","author":"Cohen","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.07.046_bib0003","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jcv.2018.03.001","article-title":"Primary Epstein-Barr virus infection","volume":"102","author":"Dunmire","year":"2018","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ijid.2022.07.046_bib0004","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1128\/JCM.42.8.3381-3387.2004","article-title":"Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years","volume":"42","author":"Hess","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2022.07.046_bib0005","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/0140-6736(93)90323-9","article-title":"Ganciclovir for chronic active Epstein-Barr virus infection","volume":"341","author":"Ishida","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2022.07.046_bib0006","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.86.16_supplement.P1.293","article-title":"Epstein Barr virus encephalitis in adults: a case series (P1.293)","volume":"86","author":"Khanal","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.ijid.2022.07.046_bib0007","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.3389\/fimmu.2017.01867","article-title":"Chronic active Epstein-Barr virus disease","volume":"8","author":"Kimura","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2022.07.046_bib0008","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood.V98.2.280","article-title":"Clinical and virologic characteristics of chronic active Epstein-Barr virus infection","volume":"98","author":"Kimura","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ijid.2022.07.046_bib0009","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fonc.2019.00062","article-title":"EBV viral loads in diagnosis, monitoring, and response assessment","volume":"9","author":"Kimura","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijid.2022.07.046_bib0010","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00043426-200106000-00012","article-title":"Vidarabine therapy for severe chronic active Epstein-Barr virus infection","volume":"23","author":"Kimura","year":"2001","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.ijid.2022.07.046_bib0011","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1128\/CMR.00044-10","article-title":"Progress and problems in understanding and managing primary Epstein-Barr virus infections","volume":"24","author":"Odumade","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijid.2022.07.046_bib0012","doi-asserted-by":"crossref","first-page":"636","DOI":"10.7326\/0003-4819-104-5-636","article-title":"Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis. Clinical and serologic features and response to antiviral chemotherapy","volume":"104","author":"Schooley","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijid.2022.07.046_bib14","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","author":"Willemze","year":"2019","journal-title":"Blood"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222004398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222004398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T10:48:43Z","timestamp":1715424523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971222004398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":13,"alternative-id":["S1201971222004398"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2022.07.046","relation":{},"ISSN":["1201-9712"],"issn-type":[{"type":"print","value":"1201-9712"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic active Epstein-Barr exacerbated by COVID-19 co-infection","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2022.07.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}